RxDoctor Payments Data

Gabriela Olivares

Optometrist · Pembroke Pines, FLNPI 1336553429

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $133,938 of the $168,070 with a category attached, or 79.7%. Johnson & Johnson Vision Care, Inc. accounts for 96.4% of it on its own, with 25 other manufacturers making up the rest. 2025 is the largest year on record at $75,106, more than ten times the $667 reported in 2019. Among optometrist clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$168,070in general payments, 2019–2025

Across 521 payments — averaging $322.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson Vision Care, Inc.$162K
  • Lumenis BE Inc$2K
  • Alcon$721
  • Maculogix, Inc.$479
  • Coopervision Inc.$387
  • Bausch & Lomb Americas Inc.$365
  • plus $2K from 20 others

What the payments were for

  • Consulting fees$5,4503%
  • Speaking & faculty fees$133,93880%
  • Travel & lodging$14,1078%
  • Food & beverage$14,5559%
  • Education$70%
  • Entertainment$130%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$168,070 in reported general payments places this provider in the 95th percentile of 3,166 optometrist providers in Florida.

See all optometrist providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine12$10,410
Prednisolone Acetate16$764
Latanoprost69$647
Timolol Maleate11$96

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRestasis$319$10,41012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,166 optometrist providers in Florida.

Other optometrist in Pembroke Pines

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →